当前位置:首页 - 行情中心 - 万孚生物(300482) - 财务分析 - 现金流量表

万孚生物

(300482)

  

流通市值:67.05亿  总市值:73.13亿
流通股本:4.29亿   总股本:4.68亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,688,341,896.091,180,359,235.7586,603,192.812,455,407,503.83
  收到的税费返还32,643,018.8432,490,311.924,716,434.5819,366,624.95
  收到其他与经营活动有关的现金48,668,640.2332,686,230.5710,953,390.8436,360,754.16
  经营活动现金流入小计1,769,653,555.161,245,535,778.19602,273,018.232,511,134,882.94
  购买商品、接受劳务支付的现金442,730,956.01261,361,551.8491,655,442.57617,224,111.5
  支付给职工以及为职工支付的现金480,944,900.52318,238,363.17173,172,391.59847,739,686.38
  支付的各项税费42,951,750.6138,868,906.4711,121,672.76124,949,520.95
  支付其他与经营活动有关的现金298,724,298.8203,068,593.59108,153,783.25458,184,003.26
  经营活动现金流出小计1,265,351,905.94821,537,415.07384,103,290.172,048,097,322.09
  经营活动产生的现金流量净额504,301,649.22423,998,363.12218,169,728.06463,037,560.85
二、投资活动产生的现金流量:
  收回投资收到的现金4,574,547,833.292,795,339,990.121,588,523,888.784,611,416,456.03
  取得投资收益收到的现金46,091,644.8431,169,132.5818,912,385.0848,704,644.77
  处置固定资产、无形资产和其他长期资产收回的现金净额58,502.0436,408.9824,948.98453,801.06
  处置子公司及其他营业单位收到的现金净额2,660,530807,660-1,009,227.87
  投资活动现金流入小计4,623,358,510.172,827,353,191.681,607,461,222.844,661,584,129.73
  购建固定资产、无形资产和其他长期资产支付的现金106,520,280.4777,533,463.2836,358,438.76304,552,406.53
  投资支付的现金4,429,752,064.143,228,859,9901,879,838,081.424,774,491,696.47
  投资活动现金流出小计4,536,272,344.613,306,393,453.281,916,196,520.185,079,044,103
  投资活动产生的现金流量净额87,086,165.56-479,040,261.6-308,735,297.34-417,459,973.27
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金1,969,515.731,374,277.71653,096.587,046,953.46
  筹资活动现金流入小计1,969,515.731,374,277.71653,096.587,046,953.46
  偿还债务支付的现金596,257,000---
  分配股利、利润或偿付利息支付的现金162,290,244.18102,664,544.18-200,577,371.67
  其中:子公司支付给少数股东的股利、利润0--2,940,000
  支付其他与筹资活动有关的现金30,020,00000216,812,245.46
  筹资活动现金流出小计788,567,244.18102,664,544.180417,389,617.13
  筹资活动产生的现金流量净额-786,597,728.45-101,290,266.47653,096.58-410,342,663.67
四、汇率变动对现金及现金等价物的影响-4,449,395.52-3,606,874.27-1,385,935.36-1,339,102.5
五、现金及现金等价物净增加额-199,659,309.19-159,939,039.22-91,298,408.06-366,104,178.59
  加:期初现金及现金等价物余额461,998,850.06461,998,850.06461,998,850.06828,103,028.65
  期末现金及现金等价物余额262,339,540.87302,059,810.84370,700,442461,998,850.06
补充资料:
  净利润-125,155,264.06--69,658,473.46
  资产减值准备-4,060,710.91-24,661,464.55
  固定资产和投资性房地产折旧-108,359,185.18-222,596,633.58
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-108,359,185.18-222,596,633.58
  无形资产摊销-18,026,558.07-35,362,085.74
  长期待摊费用摊销-1,818,637.75-5,029,881.04
  处置固定资产、无形资产和其他长期资产的损失-0--318,789.99
  固定资产报废损失-3,000,374.38-4,988,270.15
  公允价值变动损失--13,030,142.94--13,639,950.87
  财务费用-15,454,593.48-25,640,854.92
  投资损失--7,683,449.31--39,786,048.52
  递延所得税-15,739,292.81--50,760,886.55
  其中:递延所得税资产减少-21,806,608.45--36,544,624.42
    递延所得税负债增加--6,067,315.64--14,216,262.13
  存货的减少--42,841,356.08-70,340,155.59
  经营性应收项目的减少-78,730,148.97-271,583,502.28
  经营性应付项目的增加-115,606,771.37--134,926,097.1
  其他-0-106,418,000
  融资租入固定资产---1,304,714.59
  现金的期末余额-302,059,810.84-461,998,850.06
  减:现金的期初余额-461,998,850.06-828,103,028.65
  现金及现金等价物的净增加额--159,939,039.22--366,104,178.59
公告日期2026-10-282026-08-242026-04-232026-04-23
审计意见(境内)标准无保留意见
TOP↑